These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates. Faccone D, Veliz O, Corso A, Noguera M, Martínez M, Payes C, Semorile L, Maffía PC. Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514 [Abstract] [Full Text] [Related]
26. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria]. Zerbini E, Andreu D, Tonarelli G, Sequeira MD. Rev Argent Microbiol; 2006 Jan; 38(4):221-3. PubMed ID: 17370578 [Abstract] [Full Text] [Related]
27. A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses. Willcox MD, Hume EB, Aliwarga Y, Kumar N, Cole N. J Appl Microbiol; 2008 Dec; 105(6):1817-25. PubMed ID: 19016975 [Abstract] [Full Text] [Related]
28. A linguistic model for the rational design of antimicrobial peptides. Loose C, Jensen K, Rigoutsos I, Stephanopoulos G. Nature; 2006 Oct 19; 443(7113):867-9. PubMed ID: 17051220 [Abstract] [Full Text] [Related]
29. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity. Nan YH, Bang JK, Shin SY. Peptides; 2009 May 19; 30(5):832-8. PubMed ID: 19428758 [Abstract] [Full Text] [Related]
32. A C-terminal cationic fragment derived from an arginine-rich peptide exhibits in vitro antibacterial and anti-plasmodial activities governed by its secondary structure properties. Lesmes LP, Bohorquez MY, Carreño LF, Patarroyo ME, Lozano JM. Peptides; 2009 Dec 19; 30(12):2150-60. PubMed ID: 19698754 [Abstract] [Full Text] [Related]
33. Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity. Hwang H, Hyun S, Kim Y, Yu J. ChemMedChem; 2013 Jan 19; 8(1):59-62. PubMed ID: 23150226 [Abstract] [Full Text] [Related]
35. Development of novel lipid-peptide hybrid compounds with antibacterial activity from natural cationic antibacterial peptides. Oh HS, Kim S, Cho H, Lee KH. Bioorg Med Chem Lett; 2004 Mar 08; 14(5):1109-13. PubMed ID: 14980646 [Abstract] [Full Text] [Related]
37. Advances in antimicrobial peptide immunobiology. Yount NY, Bayer AS, Xiong YQ, Yeaman MR. Biopolymers; 2006 Mar 08; 84(5):435-58. PubMed ID: 16736494 [Abstract] [Full Text] [Related]
38. QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1. Frecer V. Bioorg Med Chem; 2006 Sep 01; 14(17):6065-74. PubMed ID: 16714114 [Abstract] [Full Text] [Related]
39. The pharmacophore of short cationic antibacterial peptides. Strøm MB, Haug BE, Skar ML, Stensen W, Stiberg T, Svendsen JS. J Med Chem; 2003 Apr 24; 46(9):1567-70. PubMed ID: 12699374 [Abstract] [Full Text] [Related]
40. De novo generation of short antimicrobial peptides with enhanced stability and cell specificity. Kim H, Jang JH, Kim SC, Cho JH. J Antimicrob Chemother; 2014 Jan 24; 69(1):121-32. PubMed ID: 23946320 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]